Expert sees more diagnostic, therapeutic use for nanoparticle imaging

12/2/2008 | HealthImaging.com

Recent research advances have enabled scientists to bind nanoparticles to radionuclides for MR, SPECT, PET and near-infrared optical imaging to detect inflammation or certain ailments, said Michael J. Welch, a nuclear medicine expert. He said nanoparticles will help bring a new era of diagnostic imaging and personalized medicine. The initial clinical use of nanoparticle-based agents will be for cardiac problems, Welch predicted.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX